Patents by Inventor Jacob M. Ludwig
Jacob M. Ludwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190160285Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.Type: ApplicationFiled: January 31, 2019Publication date: May 30, 2019Applicant: CARDIAC PACEMAKERS, INC.Inventors: Paul Huelskamp, Jacob M. Ludwig, Lance E. Juffer, Keith R. Maile
-
Publication number: 20190143130Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.Type: ApplicationFiled: January 14, 2019Publication date: May 16, 2019Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
-
Publication number: 20190117971Abstract: Embodiments herein relate to medical devices including volume filling leads and methods of use to treat cancerous tumors within a bodily tissue. In an embodiment, a lead for a cancer treatment system is described. The lead can include a lead body having a proximal end and a distal end, where the lead body can define a lumen. The lead can include an expandable lead head connected to the distal end of the lead body, where the lead head can be configured to be expanded between a first non-expanded position and a second expanded position in order to fill an intracorporeal void. The lead can include two or more electrodes disposed on an outer surface of the lead head and two or more electrical conductors configured to provide electrical communication between the two or more electrodes and the proximal end of the lead body. Other embodiments are also included herein.Type: ApplicationFiled: October 22, 2018Publication date: April 25, 2019Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Publication number: 20190117972Abstract: Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a medical device system for treating a cancerous tumor is described. The medical device system can include one or more electric field generating electrodes and an electric field shaping element configured to be implanted along with the one or more electric field generating electrodes. The electric field shaping element can be made from a material that alters the spatial area of tissue exposed to the electric field. Other embodiments are also included herein.Type: ApplicationFiled: October 22, 2018Publication date: April 25, 2019Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Publication number: 20190117970Abstract: Embodiments herein relate to medical devices including electric field shaping leads and methods for using the same to treat cancerous tumors within a bodily tissue. In an embodiment, an implantable lead for a cancer treatment system is disclosed. The lead can include a lead body having a proximal end and a distal end, where the lead body can define a lumen. The lead can also include a paddle disposed at the distal end of the lead body, the paddle having a width that is greater than a width of the lead body. The paddle can include one or more electrodes disposed on the paddle and one or more electrical conductors disposed within the lumen of the lead body to provide electrical communication between the one or more electrodes and the proximal end of the lead body. Other embodiments are also included herein.Type: ApplicationFiled: October 22, 2018Publication date: April 25, 2019Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Publication number: 20190117969Abstract: Embodiments herein include medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. In an embodiment, a medical device is included. The medical device can include an electric field generating circuit configured to generate one or more electric fields and control circuitry in communication with the electric field generating circuit. The control circuitry can be configured to control the generation of one or more electric fields from the electric field generating circuit. The control circuitry can cause the electric field generating circuit to deliver one or more electric fields at one or more frequencies selected from a range of between 10 kHz to 1 MHz to a cancerous tumor located within a bodily tissue. Other embodiments are also included herein.Type: ApplicationFiled: October 22, 2018Publication date: April 25, 2019Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Publication number: 20190117973Abstract: Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a method for treating a cancerous tumor is provided. The method can include implanting one or more electrodes within a patient and measuring the impedance of tissue within the patient along a vector passing through or near a cancerous tumor. The method can also include administering an electric field to the cancerous tumor of the patient based on the measured impedance. Other embodiments are also included herein.Type: ApplicationFiled: October 22, 2018Publication date: April 25, 2019Inventors: Brian L. Schmidt, Jacob M. Ludwig, Benjamin J. Haasl, Michael J. Kane
-
Patent number: 10220213Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.Type: GrantFiled: February 4, 2016Date of Patent: March 5, 2019Assignee: Cardiac Pacemakers, Inc.Inventors: Paul Huelskamp, Jacob M. Ludwig, Lance E. Juffer, Keith R. Maile
-
Patent number: 10213610Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.Type: GrantFiled: March 15, 2016Date of Patent: February 26, 2019Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
-
Publication number: 20180323865Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.Type: ApplicationFiled: July 12, 2018Publication date: November 8, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Jacob M. Ludwig, Michael J. Kane, Brendan E. Koop, William J. Linder, Keith R. Maile, Jeffrey E. Stahmann
-
Patent number: 10092763Abstract: Medical device systems and methods with multiple communication modes. An example medical device system may include a first medical device and a second medical device communicatively coupled to the first medical device. The first medical device may be configured to communicate information to the second medical device in a first communication mode. The first medical device may further be configured to communicate information to the second medical device in a second communication mode after determining that one or more of the communication pulses captured the heart of the patient.Type: GrantFiled: June 22, 2017Date of Patent: October 9, 2018Assignee: CARDIAC PACEMAKERS, INC.Inventors: Jeffrey E. Stahmann, Keith R. Maile, Brendan Early Koop, Michael J. Kane, Jacob M. Ludwig, Paul Huelskamp
-
Publication number: 20180280706Abstract: A system for recharging an implantable medical device having a rechargeable battery while the implantable medical device is implanted within a patient includes a recharge energy source configured to be disposed exterior to the patient and a recharging bridge configured to be implanted within the patient. The recharging bridge is configured to facilitate energy transfer from the recharge energy source to the implantable medical device.Type: ApplicationFiled: March 29, 2018Publication date: October 4, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Jacob M. Ludwig, William J. Linder
-
Publication number: 20180280588Abstract: An implantable medical device includes a rechargeable battery and a battery recharging assembly. The battery recharging assembly includes an energy receiver for capturing energy from an externally applied charging field, a battery charging circuit that is operably coupled to the rechargeable battery for recharging the rechargeable battery, and a demodulator that is operably coupled to the energy receiver and the battery charging circuit. The demodulator demodulates the energy captured by the energy receiver and delivers demodulated energy to the battery charging circuit to be used to charge the rechargeable battery. The IMD includes a controller that is configured to control operation of at least part of the IMD.Type: ApplicationFiled: March 29, 2018Publication date: October 4, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Jacob M. Ludwig, William J. Linder
-
Publication number: 20180280705Abstract: A system for sensing electrical cardiac activity and for providing therapy to a patient's heart. The system may include a first implantable device implanted within a patient and a second implantable device implanted near or within the heart of the patient. In some cases, the first implantable device may at least partially power the second implantable device by periodically recharging a rechargeable battery or other power source within the second implantable device. In some cases, the first implantable device may at least partially power the second implantable device by periodically, intermittently or continuously transmitting energy that may be stored by a battery, capacitor or other power storage device within the second implantable device.Type: ApplicationFiled: March 29, 2018Publication date: October 4, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Jacob M. Ludwig, Michael J. Johnson, Brendan Early Koop, Brandon Christopher Fellows, William J. Linder
-
Patent number: 10050700Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.Type: GrantFiled: March 2, 2016Date of Patent: August 14, 2018Assignee: Cardiac Pacemakers, Inc.Inventors: Jacob M. Ludwig, Michael J. Kane, Brendan E. Koop, William J. Linder, Keith R. Maile, Jeffrey E. Stahmann
-
Publication number: 20180207433Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.Type: ApplicationFiled: January 25, 2018Publication date: July 26, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Brendan Early Koop, Paul Huelskamp, Lance Eric Juffer, Kyle Leonard Nelson, Keith R. Maile, Jacob M. Ludwig
-
Publication number: 20180185655Abstract: This document discusses, among other things, systems and methods to fabricate and operate an implantable medical device. The implantable medical device can include a housing portion defining an interior chamber. The implantable medical device can include a circuit in the interior chamber. The implantable medical device can include a first electronic component that is not in the interior chamber. The implantable medical device can include a substrate coupled to the housing, the substrate including a first via extending through the substrate, the first via electrically coupling the first electronic component to the circuit.Type: ApplicationFiled: January 5, 2018Publication date: July 5, 2018Inventors: Ron A. Balczewski, James E. Blood, William J. Linder, Jacob M. Ludwig, Keith R. Maile
-
Publication number: 20180178022Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), neuro-stimulators (NS), and/or implantable monitors (IM), may be configured to communicate using more than one mode of communication and/or more than one communication vector. In some cases, the implantable medical device may be configured to switch between communication modes, vectors, and/or communication paths, which may help improve communication reliability and/or communication speed between devices.Type: ApplicationFiled: December 22, 2017Publication date: June 28, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Brendan Early Koop, William J. Linder, Keith R. Maile, Paul Huelskamp, Lance Eric Juffer, Jacob M. Ludwig
-
Publication number: 20180140853Abstract: Implantable medical devices such as leadless cardiac pacemakers may be configured to communicate using more than one mode of communication. For example, in some cases, an implantable medical device may be configured to communicate via conducted communication in some circumstances and to communicate via inductive communication in other circumstances. In some cases, the implantable medical device may be configured to switch between communication modes in order to improve communication.Type: ApplicationFiled: November 20, 2017Publication date: May 24, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, William J. Linder, Jacob M. Ludwig
-
Publication number: 20180140851Abstract: Near-field energy transmitters for charging a rechargeable power source of an implantable medical device (IMD). In some cases, the transmitter may include an output driver that may drive a transmit coil such that near-field energy is transmitted to the IMD at a determined frequency. In some cases, the IMD may include a receiving coil that may capture the near-field energy and then convert the near-field energy into electrical energy that may be used to recharge the rechargeable power source. Since the rechargeable power source does not have to maintain sufficient energy stores in a single charge for the entire expected life of the IMD, the power source itself and thus the IMD may be made smaller while still meeting device longevity requirements.Type: ApplicationFiled: November 14, 2017Publication date: May 24, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, William J. Linder, Michael J. Kane, Jeffrey E. Stahmann, Jacob M. Ludwig, Brendan Early Koop, Daniel Joseph Landherr, Greg Paul Carpenter